-
Resilience and Transformation: Pharmaceutical Stock Performance in 2023
As the dust settled from the COVID-19 pandemic, the year 2023 marked a turning point for the pharmaceutical industry.
2024-01-19 15:03 -
Advancements in Consistency Evaluation: A Comprehensive Analysis
Consistency evaluation plays a crucial role in ensuring the quality and efficacy of generic drugs. Since the implementation of the "Evaluation of Cons...
2024-01-18 15:40 -
Major Breakthrough: Xinda Biotechnology's Nylotinib Included in NCCN Guidelines for Chronic Myeloid ...
In a significant development, Xinda Biotechnology's groundbreaking drug, Nylotinib, has been recognized by the international oncology community once a...
2024-01-18 15:31 -
Ascending to the Summit: AstraZeneca Crowned as the Most Competitive MNC in China
In the realm of multinational corporations (MNCs) operating in China's healthcare sector, AstraZeneca has long been hailed as the epitome of understan...
2024-01-18 15:28 -
Breakthrough in Gastric Cancer Treatment: Claudin18.2 Antibody Enters Phase III Clinical Trials
In a significant development, the clinical trials for the third phase of gastric cancer treatment ...
2024-01-18 15:24 -
CDH6: Can It Support the Next $10.1 Billion Valuation?
The pharmaceutical industry is constantly seeking better treatment options for platinum-resistant ovarian cancer. In a recent announcement, AbbVie acq...
2024-01-18 15:21 -
Who Will Emerge as the Pharmaceutical Leader in 2024?
In the fiercely competitive pharmaceutical industry of 2024, major pharmaceutical companies are striving to innovate and secure a leading position in ...
2024-01-16 16:20 -
Restructuring at AstraZeneca China: Leadership Changes and New Business Division
AstraZeneca China recently announced significant changes within its organization, including leadership adjustments and the establishment of a new busi...
2024-01-16 15:40 -
Astellas Pharma China Announces Organizational Changes and New Business Unit Establishment
Astellas Pharma China, a leading pharmaceutical company, recently announced significant organizational changes and the establishment of a new business...
2024-01-16 15:29 -
The Rise of Bispecific ADCs in Global Pharmaceutical Industry
The pharmaceutical industry has witnessed a surge in the development of Antibody-Drug Conjugates (ADCs) in recent years.
2024-01-16 15:26
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
Related Products
Related Producers
